WallStSmart

Coca-Cola European Partners PLC (CCEP)vsBeauty Health Co (SKIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 6958% more annual revenue ($20.90B vs $296.12M). CCEP leads profitability with a 9.3% profit margin vs -2.0%. SKIN appears more attractively valued with a PEG of 0.93. CCEP earns a higher WallStSmart Score of 57/100 (C).

CCEP

Buy

57

out of 100

Grade: C

Growth: 6.7Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

SKIN

Hold

44

out of 100

Grade: D

Growth: 2.7Profit: 2.0Value: 6.0Quality: 4.5
Piotroski: 6/9Altman Z: -0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP3 strengths · Avg: 9.3/10
Return on EquityProfitability
42.9%10/10

Every $100 of equity generates 43 in profit

EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

SKIN2 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

PEG RatioValuation
0.938/10

Growing faster than its price suggests

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.383/10

Elevated debt levels

PEG RatioValuation
2.722/10

Expensive relative to growth rate

SKIN4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$84.90M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

Revenue GrowthGrowth
-6.7%2/10

Revenue declined 6.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, EPS Growth, Free Cash Flow.

Bull Case : SKIN

The strongest argument for SKIN centers on Price/Book, PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 6.65 is elevated, increasing financial risk.

Key Dynamics to Monitor

CCEP profiles as a value stock while SKIN is a turnaround play — different risk/reward profiles.

SKIN carries more volatility with a beta of 1.07 — expect wider price swings.

CCEP is growing revenue faster at 0.2% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (57/100 vs 44/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Want to dig deeper into these stocks?